Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$30.2K
6.60K shares
What this filing means
CARTER TODD ALFRED plans to sell 6.60K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $30.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2025ACC: 0001959173-25-000885
Officer· Chief Scientific Officer
Since Feb 2026
6.60K
Shares to sell
$30.2K
Approx. market value
5.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/7/2025
5.41KTotal acquired5.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2025 | Restricted Stock Vesting Compensation | 5.41K | — |
| Total | 5.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.19K
Market value
$6.1K
1/14/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.41K
Market value
$24.1K
2/11/2025
Total
Units
6.60K
Value
$30.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/14/2025 | 1.19K | $6.1K | — | Completed |
| Planned — Approximate Date | ||||
2/11/2025 | 5.41K | $24.1K | NASDAQ | Planned |
| Total | 6.60K | $30.2K | ||